Grail (GRAL) Net Cash Flow (2023 - 2026)
Grail's (GRAL) quarterly Net Cash Flow came in at -$127.3 million in Q2 2026, down 1830.05% on a YoY basis from $7.4 million in Q2 2025, and up 29.44% quarter-over-quarter from -$180.4 million in Q1 2026.
Analysis
Grail (GRAL) Net Cash Flow (2023 - 2026) Analysis & Trends
Grail (GRAL) has reported Net Cash Flow for 4 consecutive years, with -$127.3 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Cash Flow fell 1830.05% year-over-year to -$127.3 million; the trailing twelve-month figure through Jun 2026 stood at -$181.5 million (up 78.19% YoY), and the FY2025 full-year result was $39.3 million, down 66.19% from the prior year.
- Net Cash Flow grew to -$127.3 million in Q2 2026 per GRAL's latest filing, from -$180.4 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $759.1 million in Q2 2024 and bottomed at -$639.6 million in Q4 2024.
- Historically, Net Cash Flow has averaged -$23.8 million across 4 years, with a median of -$63.6 million in 2023.
- The sharpest annual moves came in 2025 and 2026: Net Cash Flow soared 119.2% in 2025, then plunged 1830.05% in 2026.
- Over 4 years, Net Cash Flow stood at -$46.8 million in 2023, then sank by 1266.45% to -$639.6 million in 2024, then jumped by 119.2% to $122.8 million in 2025, then slumped by 203.64% to -$127.3 million in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered -$127.3 million, -$180.4 million, and $122.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | 3.57 Mn |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 234.00 Mn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | -840.60 Mn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | 66.71 Mn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | 78.50 Mn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | -130.62 Mn |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 42.79 Mn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | 11.18 Mn |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | 92.31 Mn |
| 10 | Grail | 3.61 Bn | 2.75 Bn | 21.34 Mn | -127.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -127.31 Mn |
| Mar 31, 2026 | -180.43 Mn |
| Dec 31, 2025 | 122.83 Mn |
| Sep 30, 2025 | 3.43 Mn |
| Jun 30, 2025 | -6.60 Mn |
| Mar 31, 2025 | -80.40 Mn |
| Dec 31, 2024 | -639.60 Mn |
| Sep 30, 2024 | -105.55 Mn |
| Jun 30, 2024 | 759.12 Mn |
| Mar 31, 2024 | 102.17 Mn |
| Dec 31, 2023 | -46.81 Mn |
| Oct 1, 2023 | -86.58 Mn |